1. Home
  2. NSPR vs REFR Comparison

NSPR vs REFR Comparison

Compare NSPR & REFR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo InspireMD Inc.

NSPR

InspireMD Inc.

HOLD

Current Price

$1.63

Market Cap

67.4M

Sector

Health Care

ML Signal

HOLD

Logo Research Frontiers Incorporated

REFR

Research Frontiers Incorporated

HOLD

Current Price

$1.15

Market Cap

54.8M

Sector

Miscellaneous

ML Signal

HOLD

Company Overview

Basic Information
Metric
NSPR
REFR
Founded
2005
1965
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Multi-Sector Companies
Sector
Health Care
Miscellaneous
Exchange
Nasdaq
Nasdaq
Market Cap
67.4M
54.8M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
NSPR
REFR
Price
$1.63
$1.15
Analyst Decision
Buy
Analyst Count
1
0
Target Price
$4.00
N/A
AVG Volume (30 Days)
35.3K
46.7K
Earning Date
03-11-2026
03-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$7,779,000.00
$1,227,276.00
Revenue This Year
$22.76
N/A
Revenue Next Year
$75.45
N/A
P/E Ratio
N/A
N/A
Revenue Growth
14.04
N/A
52 Week Low
$1.51
$0.93
52 Week High
$3.80
$2.70

Technical Indicators

Market Signals
Indicator
NSPR
REFR
Relative Strength Index (RSI) 40.66 31.66
Support Level $1.53 $1.21
Resistance Level $1.70 $1.32
Average True Range (ATR) 0.11 0.08
MACD 0.01 -0.00
Stochastic Oscillator 45.65 5.77

Price Performance

Historical Comparison
NSPR
REFR

About NSPR InspireMD Inc.

InspireMD Inc is a United States based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System (MGuard Prime EPS). It generates the majority of the revenue from the sales of CGuard EPS which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The group operates in Italy, Germany, Russia and other countries.

About REFR Research Frontiers Incorporated

Research Frontiers Inc is engaged in the development and marketing of technology and devices to control the flow of light. The company develops and licenses its patented suspended particle device light-control technology to other companies that manufacture and market the SPD-Smart chemical emulsion, the light-control film made from the chemical emulsion, the light-control panels made by laminating the film, electronics to power end-products incorporating the film, or lamination services for, and the end-products. The company's revenue source comes from the licensing of technology.

Share on Social Networks: